At present, there is no discernible evidence of a cross-cutting or all-of-government strategy to increase the commercial dividends from the scientific capital we have accumulated in the biological sciences.
A 2017 report from Deloitte and BIOTECanada found 59 per cent of the companies said they were looking to government as their first source of future financing—the vast majority of such government funding comes through Innovation, Science, and Economic Development Canada, which is overseen by Navdeep Bains, pictured, as minister. The Hill Times photograph by Andrew Meade
TORONTO—Canada is rich in the scientific capital needed to make us a serious player in the transformative world of biotechnology.
People. Policy. Politics. This is an exclusive subscriber-only story.
'We have to move beyond public platitudes and eloquent statements; we need a reality whereby Indigenous law and institutions are placed on the same level as common law,' says Grand Chief Stewart Phillip.